Karl Hrd Email & Phone Number | Experienced Head of Investor Relations and Communications with a demonstrated history of delivering shareholder value in the pharmaceutical and biotechnology industries. Skilled in Investor Relations, Corporate Communications, Fund Raising, Strategy, Cross-functional Team Leadership, and Valuation. Strong media and communication professional with a Ph.D.

Karl Hrd

Experienced Head of Investor Relations and Communications with a demonstrated history of delivering...
Stockholm, Stockholm, Sweden

*50 free lookup(s) per month.

Karl Hrd’s Phone Numbers

Get KARL’s Phone Number (For Free)

Social Media

Karl Hrd’s Location Stockholm, Stockholm, Sweden

Karl Hrd’s Current Industry Egetis Therapeutics

Find accurate emails & phone numbers for over 700M professionals.

Head of Investor Relations and Communication

2022-02-01 00:00:00 - Present

Head of Investor Relations

2021-09-01 00:00:00 - 2022-02-01 00:00:00

Investor Relations and Communications Consultant

2019-01-01 00:00:00 - 2021-09-01 00:00:00

Head of Investor Relations and Communications

2017-09-01 00:00:00 - 2018-12-01 00:00:00

VP Investor Relations

2014-01-01 00:00:00 - 2016-06-01 00:00:00

Assistant Professor Of Chemistry

1996-01-01 00:00:00 - 1997-01-01 00:00:00

Supervisor, European Large Scale NMR Facility

1994-01-01 00:00:00 - 1996-01-01 00:00:00

No Skills Available

No Languages Available

Karl Hrd is a Experienced Head of Investor Relations and Communications with a demonstrated history of delivering shareholder value in the pharmaceutical and biotechnology industries. Skilled in Investor Relations, Corporate Communications, Fund Raising, Strategy, Cross-functional Team Leadership, and Valuation. Strong media and communication professional with a Ph.D.

Karl Hrd has prior
experience in the following industries:
Redx Pharma | Self Employed And Optimum Strategic Communications | Kiadis Pharma | Astrazeneca | Universiteit Leiden | Universiteit Utrecht

Karl Hrd has the following professional experience:
Egetis Therapeutics | Redx Pharma | Self Employed And Optimum Strategic Communications | Kiadis Pharma | Astrazeneca | Universiteit Leiden | Universiteit Utrecht